US 10,517,542 B2 · Using biomarker information for heart failure risk computation

Abstract

Provided is a method, system and/or apparatus for determining prospective heart failure event risk. Acquired from a device memory are a heart failure patient's current and preceding risk assessment periods. Counting detected data observations in the current risk assessment period for a current risk assessment total amount and counting detected data observations in the preceding risk assessment period for a preceding risk assessment period total amount. Associating the current risk assessment and preceding risk assessment total amounts with a lookup table to acquire prospective risk of heart failure (HF) event for the preceding risk assessment period and the current risk assessment period. Employing weighted sums of the prospective risk of the HF event for the preceding risk assessment period and the current risk assessment period to calculate a weighted prospective risk of the HF event for a patient. Displaying on a graphical user interface the weighted prospective risk of the HF event for the patient.

Claims6

Dependent claims

A method of operation of a medical system for determining prospective heart failure event risk, the method comprising:

(a) acquiring from a device memory a heart failure patient's current and preceding risk assessment periods;
(b) counting detected data observations in the current risk assessment period for a current risk assessment total amount and counting detected data observations in the preceding risk assessment period for a preceding risk assessment period total amount;
(c) associating the current risk assessment and preceding risk assessment total amounts with a lookup table to acquire prospective risk of heart failure (HF) event for the preceding risk assessment period and the current risk assessment period;
(d) employing weighted sums of the prospective risk of the HF event for the preceding risk assessment period and the current risk assessment period to calculate a weighted prospective risk of the HF event for the patient;
(e) using the prospective risk to modify therapy delivered by an implantable device;
and
(f) delivering the modified therapy to the patient using the implantable device.

4 more elements

Dependencies are inferred from the claim text.

Using biomarker information for heart failure risk computation

Life of this patent

Using biomarker information for heart failure risk computation

Life of this patent

Abstract

Claims6